2m 2m 2m 2m 2m 2m 2m
LIFESTANCE HLTH (LFST)
NASDAQ
$9.45+$0.25 (+2.67%)
Price as of Jun 23, 2026 6:10 PM EDT- $3.5BMarket Cap
- 85.58%1-Year Change
- Medical Care FacilitiesIndustry
LIFESTANCE HLTH (LFST)
$9.45+$0.25 (+2.67%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.4B +13.85% | 1.3B +18.50% | 1.1B +22.82% | 859.5M +28.77% | |
Cost of Revenue | N/A N/A | N/A N/A | 1.6M N/A | N/A N/A | |
Gross Profit | 1.4B +13.85% | 1.3B +18.68% | 1.1B +22.64% | 859.5M +28.77% | |
Sales and Marketing Expense | 382.2M +5.27% | 363.1M -11.62% | 410.8M +8.68% | 378.0M -12.85% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 54.8M -22.83% | 71.0M -11.79% | 80.4M +16.24% | 69.2M +27.82% | |
Total Operating Expenses | 1.4B +9.17% | 1.3B +3.04% | 1.2B +16.37% | 1.1B +12.15% | |
Operating Profit | 24.1M +176.39% | -31.6M -83.29% | -189.1M -10.01% | -210.2M -26.60% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -11.7M -56.05% | -26.5M +25.05% | -21.2M +6.48% | -19.9M -48.79% | |
Interest Income and Expense and Net | -11.7M -56.05% | -26.5M +25.05% | -21.2M +6.48% | -19.9M -48.79% | |
Total Nonoperating Income and Expense | -11.8M -54.67% | -26.0M +49.01% | -17.4M -22.64% | -22.6M -51.75% | |
Income before Taxes | 12.4M +121.46% | -57.6M -72.11% | -206.6M -11.23% | -232.7M -30.13% | |
Income Taxes | 2.7M +1,688.24% | -170,000 -99.16% | -20.3M +18.38% | -17.2M -33.74% | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | N/A N/A | |
Net Income | 9.7M +116.82% | -57.4M -69.16% | -186.3M -13.59% | -215.6M -37.33% | |
Net Income from Continuing Operations Applicable to Common | 12.4M +121.46% | -57.6M -69.07% | -186.3M -13.59% | -215.6M -37.33% | |
Basic EPS and Net Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Diluted EPS and Net Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Basic Weighted Average Shares | 386.0M +1.81% | 379.1M +103,081.32% | 367,457 +3.43% | 355,278 +8.47% | |
Diluted Weighted Average Shares | 391.1M +3.16% | 379.1M +103,081.32% | 367,457 +3.43% | 355,278 +8.47% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 248.6M +60.86% | 154.6M +96.10% | 78.8M -27.43% | 108.6M -26.62% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 248.6M +60.86% | 154.6M +96.10% | 78.8M -27.43% | 108.6M -26.62% | |
Total Current Assets | 416.2M +33.18% | 312.5M +38.44% | 225.7M -3.21% | 233.2M -12.49% | |
Accumulated Depreciation | 132.1M +42.99% | 92.4M +34.48% | 68.7M +60.17% | 42.9M +119.62% | |
Property and Plant and Equipment and Net | 161.6M -2.68% | 166.0M -11.78% | 188.2M -3.07% | 194.2M +27.55% | |
Total Long-Term Assets | 1.8B -1.00% | 1.8B -4.16% | 1.9B -2.91% | 1.9B +16.87% | |
Total Assets | 2.2B +4.04% | 2.1B +0.39% | 2.1B -2.94% | 2.2B +12.80% | |
Income Taxes Payable | 16.4M +14.51% | 14.3M -7.98% | 15.6M -59.76% | 38.7M -28.70% | |
Total Short-Term Debt | 14.5M +100.00% | 7.3M +147.86% | 2.9M +24.73% | 2.3M -89.00% | |
Total Current Liabilities | 252.0M +10.08% | 228.9M +12.82% | 202.9M +15.27% | 176.0M +50.75% | |
Total Long-Term Debt | 265.9M -4.95% | 279.8M -0.18% | 280.3M +24.53% | 225.1M +42.98% | |
Total Long-Term Liabilities | 431.0M -2.75% | 443.1M -7.33% | 478.2M -0.21% | 479.1M +80.59% | |
Total Liabilities | 682.9M +1.62% | 672.0M -1.33% | 681.0M +3.95% | 655.1M +71.47% | |
Retained Earnings | -808.6M -1.18% | -818.3M +7.55% | -760.8M +32.87% | -572.6M +60.37% | |
Total Stockholders Equity | 1.5B +5.17% | 1.4B +1.21% | 1.4B -5.91% | 1.5B -1.70% | |
Total Shares Outstanding | 388.3M +1.46% | 382.7M +1.06% | 378.7M +0.73% | 376.0M +0.46% | |
Cash Flow | |||||
Cash from Operating Activities | 146.2M +36.26% | 107.3M +735.28% | -16.9M -131.98% | 52.8M +460.39% | |
Capital Expenditures | 36.1M +67.51% | 21.6M -46.78% | 40.5M -48.87% | 79.3M -16.13% | |
Cash from Investing Activities | -36.1M +67.51% | -21.6M -64.26% | -60.3M -56.73% | -139.5M -28.14% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -16.0M +60.40% | -9.9M -120.97% | 47.4M +0.34% | 47.3M -84.94% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | 99.85% N/A | N/A N/A | |
Operating Margin | 1.70% +167.09% | -2.53% -85.89% | -17.92% -26.73% | -24.45% N/A | |
Return on Assets | 0.45% +116.46% | -2.72% -68.75% | -8.70% -17.28% | -10.51% N/A | |
Return on Equity | 0.65% +116.30% | -4.00% -68.38% | -12.64% -10.19% | -14.07% N/A | |
Revenue Growth | 13.85% -25.11% | 18.50% -18.92% | 22.82% -20.69% | 28.77% N/A | |
Current Ratio | 1.65 +20.98% | 1.37 +22.71% | 1.11 -16.03% | 1.33 N/A | |
Cash Ratio | 0.99 +46.13% | 0.68 +73.82% | 0.39 -37.05% | 0.62 N/A | |
Debt-to-Equity Ratio | 0.18 -7.10% | 0.20 +0.15% | 0.20 +32.40% | 0.15 N/A | |
Debt-to-Assets Ratio | 0.13 -6.13% | 0.14 +0.97% | 0.13 +28.30% | 0.10 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow